PT - JOURNAL ARTICLE AU - Nichols, Emma Hitt ED - Birnie, David TI - Continued Warfarin Better than Heparin Bridging during Device Implantation DP - 2013 Jul 01 TA - MD Conference Express PG - 10--10 VI - 13 IP - 3 4099 - http://mdc.sagepub.com/content/13/3/10.short 4100 - http://mdc.sagepub.com/content/13/3/10.full AB - Importantly, up to 35% of patients that undergo arrhythmic device implantation also require chronic anticoagulant treatment. Current clinical practice guidelines recommend discontinuing warfarin treatment prior to surgery and treating patients with low-molecular-weight heparin [Douketis JD et al. Chest 2012]. This article presents data from the Bridge or Continue Coumadin for Device Surgery Randomized Controlled Trial [BRUISE CONTROL; Birnie D et al. N Engl J Med 2013], which tested the hypothesis that continued treatment with warfarin would reduce the number of device-pocket hematomas without increasing the risk of major perioperative bleeding events.